Marien Pharma-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 0.64 M
as on 21-12-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.70 M
as on 21-12-2024
- Revenue 38.58%
(FY 2017)
- Profit 119.99%
(FY 2017)
- Ebitda 12.06%
(FY 2017)
- Net Worth 3.39%
(FY 2017)
- Total Assets 2.97%
(FY 2017)
About Marien Pharma-Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.64 M.
The company currently has active open charges totaling ₹7.70 M.
Rajesh Banger, Nitesh Gupta, and Nilesh Gupta serve as directors at the Company.
- CIN/LLPIN
U24232MP2002PTC015108
- Company No.
015108
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Marien Pharma-Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Banger  | Director | 21-May-2002 | Current |
| Nitesh Gupta | Director | 21-May-2002 | Current |
| Nilesh Gupta | Director | 21-May-2002 | Current |
Financial Performance of Marien Pharma-Tech.
Marien Pharma-Tech Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 38.58% increase. The company also saw a substantial improvement in profitability, with a 119.99% increase in profit. The company's net worth moved up by a moderate rise of 3.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marien Pharma-Tech?
In 2017, Marien Pharma-Tech had a promoter holding of 95.33% and a public holding of 4.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 25 May 2011 | ₹2.70 M | Open |
Dena Bank Creation Date: 18 May 2010 | ₹5.00 M | Open |
How Many Employees Work at Marien Pharma-Tech?
Unlock and access historical data on people associated with Marien Pharma-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marien Pharma-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marien Pharma-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
